Effect of flash-heat treatment on immunoglobulins in breast milk.

Caroline J Chantry, Kiersten Israel-Ballard, Zina Moldoveanu, Jan Peerson, Anna Coutsoudis, Lindiwe Sibeko, Barbara Abrams
Author Information
  1. Caroline J Chantry: Department of Pediatrics, University of California Davis Medical Center, Sacramento, CA 95817, USA. caroline.chantry@ucdmc.ucdavis.edu

Abstract

BACKGROUND: Heat-treated expressed breast milk is recommended by the World Health Organization as an option to reduce vertical HIV transmission in resource-poor regions. Flash-heat (FH) is a low technology pasteurization method developed for home use, but its effect on quantity and quality of breast milk immunoglobulins is unknown.
OBJECTIVE: To evaluate FH's effect on breast milk immunoglobulin levels and antigen-binding capacity.
DESIGN/METHODS: Fifty HIV+ mothers in South Africa provided breast milk. Part of each sample served as an unheated control; the remainder was flash-heated. Total and antigen-specific immunoglobulin A (IgA) and immunoglobulin G (IgG) were measured by enzyme-linked immunosorbent assay. Paired t test was performed on log-transformed data.
RESULTS: FH significantly decreased total IgA and IgG concentrations [geometric mean (geometric SD) 318.0 (1.9) vs. 398.2 (1.9) microg/mL and 89.1 (2.7) vs. 133.3 (2.5) microg/mL, P < 0.001 each]. Similar decreases in anti-HIV-1 gp120 IgG, anti-pneumococcal polysaccharide, and anti-poliovirus IgA occurred (P < 0.001 each). Although the latter was most affected, FH retained 66% of the antigen-binding ability. In contrast, binding capacity of IgA and IgG to influenza increased after FH (P = 0.029 and 0.025, respectively).
CONCLUSIONS: Most breast milk immunoglobulin activity survives FH, suggesting flash-heated breast milk is immunologically superior to breast milk substitutes. Clinical significance of this decreased immunoglobulin activity needs evaluation in prospective trials.

References

  1. PLoS Med. 2007 Jan;4(1):e17 [PMID: 17227132]
  2. Adv Exp Med Biol. 2001;501:341-8 [PMID: 11787700]
  3. J Pediatr Gastroenterol Nutr. 1982;1(3):381-4 [PMID: 7186050]
  4. J Pediatr. 1977 Dec;91(6):897-900 [PMID: 336859]
  5. Early Hum Dev. 1977 Dec;1(3):227-45 [PMID: 363402]
  6. J Pediatr. 1979 Jan;94(1):1-9 [PMID: 363994]
  7. J Food Prot. 1988 Feb;51(2):132-136 [PMID: 30978771]
  8. J Pediatr (Rio J). 2007 Jan-Feb;83(1):59-63 [PMID: 17279281]
  9. J Diarrhoeal Dis Res. 1996 Jun;14(2):90-4 [PMID: 8870401]
  10. Arch Dis Child. 1998 Mar;78(3):235-9 [PMID: 9613353]
  11. Pediatrics. 2006 Apr;117(4):e701-10 [PMID: 16585284]
  12. JAMA. 2000 Mar 1;283(9):1167-74 [PMID: 10703779]
  13. J Pediatr. 1982 Apr;100(4):563-7 [PMID: 6977634]
  14. Clin Immunol. 2001 Aug;100(2):250-9 [PMID: 11465955]
  15. N Engl J Med. 2008 Jul 10;359(2):130-41 [PMID: 18525036]
  16. Am J Clin Nutr. 1983 Apr;37(4):632-40 [PMID: 6837495]
  17. J Pediatr. 1977 Jan;90(1):29-35 [PMID: 318682]
  18. Arch Dis Child. 1978 Mar;53(3):239-41 [PMID: 306224]
  19. Breastfeed Med. 2007 Mar;2(1):27-33 [PMID: 17661617]
  20. AIDS. 2001 Feb 16;15(3):379-87 [PMID: 11273218]
  21. J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):318-23 [PMID: 17514015]
  22. JAMA. 2001 Nov 21;286(19):2413-20 [PMID: 11712936]
  23. J Pediatr. 1984 Mar;104(3):380-5 [PMID: 6323663]
  24. J Acquir Immune Defic Syndr. 2008 Aug 1;48(4):444-9 [PMID: 18614920]
  25. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):175-81 [PMID: 16186735]

Grants

  1. R21 HD051473/NICHD NIH HHS
  2. R21 HD051473-01/NICHD NIH HHS

MeSH Term

Antibodies, Bacterial
Developing Countries
Female
HIV Antibodies
HIV Infections
Hot Temperature
Humans
Immunoglobulin A
Immunoglobulin G
Infectious Disease Transmission, Vertical
Milk, Human
South Africa
Sterilization
Virus Inactivation

Chemicals

Antibodies, Bacterial
HIV Antibodies
Immunoglobulin A
Immunoglobulin G

Word Cloud

Created with Highcharts 10.0.0breastmilkFHimmunoglobulin0IgAIgG12Peffectimmunoglobulinsantigen-bindingcapacityflash-heateddecreased9vsmicrog/mL<001activityBACKGROUND:Heat-treatedexpressedrecommendedWorldHealthOrganizationoptionreduceverticalHIVtransmissionresource-poorregionsFlash-heatlowtechnologypasteurizationmethoddevelopedhomeusequantityqualityunknownOBJECTIVE:evaluateFH'slevelsDESIGN/METHODS:FiftyHIV+mothersSouthAfricaprovidedPartsampleservedunheatedcontrolremainderTotalantigen-specificGmeasuredenzyme-linkedimmunosorbentassayPairedttestperformedlog-transformeddataRESULTS:significantlytotalconcentrations[geometricmeangeometricSD31839889713335each]Similardecreasesanti-HIV-1gp120anti-pneumococcalpolysaccharideanti-poliovirusoccurredAlthoughlatteraffectedretained66%abilitycontrastbindinginfluenzaincreased=029025respectivelyCONCLUSIONS:survivessuggestingimmunologicallysuperiorsubstitutesClinicalsignificanceneedsevaluationprospectivetrialsEffectflash-heattreatment

Similar Articles

Cited By